Form 8.3 - Willis Towers Watson plc - Amendment

LONDON--()-- 

Ap19

FORM 8.3 - Amendment to sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 28 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,815,773

1.41%

240,933

0.19%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

202,408

0.16%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,894,232

1.47%

449,441

0.35%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

1

234.5950 USD
Purchase

30

234.2000 USD
Purchase

35

231.7700 USD
Purchase

100

234.2400 USD
Purchase

104

234.2200 USD
Purchase

200

231.6550 USD
Purchase

257

234.2394 USD
Purchase

398

233.5038 USD
Purchase

437

234.2230 USD
Purchase

485

231.9650 USD
Purchase

937

231.3248 USD
Purchase

1,717

231.7466 USD
Purchase

2,474

232.0443 USD
Purchase

2,853

231.5213 USD
Purchase

7,308

232.6257 USD
Purchase

10,220

231.8467 USD
Purchase

11,460

231.3700 USD
Purchase

11,530

231.6052 USD
Sale

1

231.1900 USD
Sale

18

233.0572 USD
Sale

100

232.1400 USD
Sale

100

232.3100 USD
Sale

108

231.3451 USD
Sale

136

234.1573 USD
Sale

164

231.7370 USD
Sale

196

232.8606 USD
Sale

200

233.3800 USD
Sale

201

231.8704 USD
Sale

230

232.1847 USD
Sale

264

233.1585 USD
Sale

298

233.9044 USD
Sale

421

232.0376 USD
Sale

422

231.8417 USD
Sale

425

231.9494 USD
Sale

616

232.2276 USD
Sale

928

234.2283 USD
Sale

1,114

232.1996 USD
Sale

1,428

231.9688 USD
Sale

1,524

231.3688 USD
Sale

1,859

231.9849 USD
Sale

2,501

231.3712 USD
Sale

2,700

232.3445 USD
Sale

2,834

232.9420 USD
Sale

3,828

231.8592 USD
Sale

3,955

231.5683 USD
Sale

4,980

231.7292 USD
Sale

9,416

231.3700 USD
Sale

11,559

231.5531 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure:

30 Jun 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

 

Category Code: RET
Sequence Number: 740438
Time of Receipt (offset from UTC): 20210630T112230+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC